Propensity-Matched Survival Analysis of Upper Urinary Tract Urothelial Carcinomas between End-Stage Renal Disease with and without Kidney Transplantation
Table 1
Patient demography.
Primary cohort
Propensity-matched cohort
ESRD
ESRD
p value
ESRD
ESRD
p value
no KT
KT
no KT
KT
n=151
n=43
n=110
n=38
FU (months)
43.7±35.4
50.2±35.8
0.289
43.2±35.8
50.8±36.6
0.265
Age(years)
63.4±11.1
56.7±7.4
<0.001
63.7±11.1
57.4±7.1
0.001
Male/Female
95/56
28/15
0.791
41/69
14/24
0.962
pT stage
0.227
0.831
pTa/Tis
48
13
37
10
pT1
49
10
32
10
pT2
22
9
16
8
pT3
28
10
22
9
pT4
4
1
3
1
Papillary
123
33
0.492
91
29
0.384
Multifocal
56
26
<0.001
51
21
0.344
BC history
79
19
0.347
High grade
139
41
0.461
101
36
0.554
LVI
21
6
0.994
14
6
0.634
CIS
73
31
0.006
65
26
0.308
Variant UC
43
11
0.709
33
10
0.666
5-year SR
10
9
0.014
9
9
0.030
5-year CD
8
5
0.237
7
5
0.314
FU: follow-up duration, BC: bladder cancer, LVI: lymphovascular invasion, CIS: carcinoma in situ, UC: urothelial carcinoma, SR: systemic recurrence, and CD: cancer-related death. Multifocal: concurrent renal pelvis and ureteral cancer.
